Image Source: Unsplash

Tsumura Co (TSMRF) was founded by Jusha Tsumura on April 10, 1893 and is headquartered in Tokyo, Japan.

The company manufactures and sells Kampo medicine, a traditional form of medicine in Japan.

Three key data points gauge Tsumura or any dividend paying entity, namely:

(1) Price

(2) Dividends

(3) Returns

Those keys also indicate if any company has made, is making, and will make money.

TSMRF Price

Tsumura share price fell 17% from $26.76 to $22.20 over the past year perThursday’s market price.

No analysts cover the stock. However 2 years of price history show TSMRF stock price growing an average of$2.01 per year.

That increase could move the stock price to $25.20 by next September.

TSMRF Dividends

Tsumura has paid semi-annual variable dividends since July 1987.

The current forward looking annual $0.92 dividend yields 3.97% per Thursday’s $23.20 share price.

TSMRF Returns

Putting it all together, a $2.92 estimated gross gain per share shows up when adding TSMRF’s annual $0.92 dividend to an estimated $2.00 annual price gain.

A little under $1000 invested at the recent $23.20 share price would buy43 shares which, multiply the $2.92 gross gain to an estimated $125.86 for the coming year.

Over 31.5% of that $126.00 gain comes from the $39.70 of annual dividends generated from your $1,000 investment.

Besides, the $39.70 annual dividend from your $1k investment is about 1.7 times greater than the recent $23.20 single-share price.

(A dividend dogcatcher rule is to only buy initial shares of a stock that pays an annual dividend from $1000 invested that is greater than the cost of a single share.)

Therefore, you may choose to pounce on TSMRF to get that current $39.70 annual dividend income that has been paid out over the past 38 years.

The exact track of TSMRF’s future share price and dividends will entirely be determined by market action and company finances.

Remember the best way to track stock performance and dividend payments is through direct ownership of company shares.

More By This Author:

Summary Report: Spok Holdings
Summary Report: Sienna Senior Living
Summary Report: Extendicare